Thermo Fisher Scientific Inc.
Cash Flow Statement
| Line Item | FY2009 | FY2008 | FY2007 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | $850.3M | $980.9M | $748.4M |
| Depreciation & Amortization | $762.9M | $792.7M | $756.8M |
| Depreciation | $183.0M | $189.9M | — |
| Amortization | $579.9M | $602.8M | — |
| Stock-Based Compensation | $67.0M | $57.1M | $51.1M |
| Net Cash from Operating Activities | $1.66B | $1.42B | $1.48B |
| Investing Activities | |||
| Capital Expenditures | $200.0M | $264.4M | $175.5M |
| Business Acquisitions | $637.3M | $201.5M | $492.5M |
| Net Cash from Investing Activities | $-829.5M | $-450.0M | $-586.0M |
| Financing Activities | |||
| Dividends Paid | — | — | — |
| Stock Repurchases | $414.6M | $187.4M | $898.0M |
| Net Cash from Financing Activities | $-557.5M | $-228.4M | $-928.7M |
| Net Change in Cash | $283.6M | $655.4M | $-42.3M |
| Free Cash Flow | $1.46B | $1.16B | $1.31B |